Article Sidebar
Published:
Mar 15, 2019Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Pharmacokinetics of enantiomers of oxiracetam in rats
Abstract
Methods: Sprague-Dawley rats (20) were randomly divided into two groups (ten rats per group), viz, SORT and R-ORT groups. Rats in S-ORT group received 200 mg S-ORT/kg while rats in R-ORT group were given 200 mg R-ORT/kg. Both treatments were given orally, and blood samples were collected at fixed time intervals for analysis. Ultra performance liquid chromatography-electrospray ionizationtandem mass spectrometry (UPLC–ESI-MS/MS) was used for pharmacokinetic analysis. Portions of the rat plasma were also subjected to configurational transformation analysis using normal phase-high performance liquid chromatographic (NP-HPLC) fitted with a Chiral OC column. Blank blood samples from five rats were used for plasma protein binding rate studying.
Results: The two enantiomers did not transform into each other after oral administration, and the concentrations of S-ORT at 1, 1.5 and 2 h were significantly higher than those of R-ORT (p < 0.05). The area under the curve (AUC0-∞) and maximum concentration (Cmax) of S-ORT were also significantly larger than those of R-ORT (p < 0.05). There were no stereoselective differences between the two enantiomers.
Conclusion: There are significant differences in absorption between two ORT enantiomers, and this may result in different pharmacological effects.
Keywords: S-oxiracetam, R-oxiracetam, Configuration, Pharmacokinetics, Rats
